Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Todd Christopher Longsworth currently holds 62,462 shares of NovoCure Ltd (NVCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Todd Christopher Longsworth has been a net seller of NVCR stock. They have purchased $0 and sold $31.1M worth of shares.
Todd Christopher Longsworth's most recent insider trade was on Mar 8, 2022, when they sold 2,339 shares at $70.10 per share.
Todd Christopher Longsworth serves as Executive at NovoCure Ltd (NVCR). They have executed 83 insider transactions totaling $31.1M over their tenure at the company.
Todd Christopher Longsworth holds the position of Executive at NovoCure Ltd, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Todd Christopher Longsworth has shown a selling trading pattern, with $0 in total purchases and $31.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Todd Christopher Longsworth was on Sep 3, 2019, when they sold $2.5M worth of NVCR shares. This transaction involved 28,340 shares at $88.17 per share.
Todd Christopher Longsworth currently owns 62,462 shares of NovoCure Ltd (NVCR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Todd Christopher Longsworth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Todd Christopher Longsworth has 83 Form 4 filings on record as an insider at NovoCure Ltd.
Set alerts for Todd Christopher Longsworth and 40,000+ other insiders.